about
Biochemical markers of bone turnover in benign paroxysmal positional vertigoAssociations between the 2007 Medicare reimbursement reduction for bone mineral density testing and osteoporosis drug therapy patterns of female Medicare beneficiaries.Is bone microarchitecture status of the lumbar spine assessed by TBS related to femoral neck fracture? A Spanish case-control study.Socioeconomic status, race, and bone turnover in the Midlife in the US Study.Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures.Clinical use of bone turnover markers to monitor pharmacologic fracture prevention therapy.Advances in bone imaging for osteoporosis.Osteoporosis in older persons: current pharmacotherapy and future directions.Fracture prediction from repeat BMD measurements in clinical practice.Role of Side Effects, Physician Involvement, and Patient Perception in Non-Adherence with Oral Bisphosphonates.Manipulating bone disease in inflammatory bowel disease patients.Evaluating spine micro-architectural texture (via TBS) discriminates major osteoporotic fractures from controls both as well as and independent of site matched BMD: the Eastern European TBS study.Seasonal variation of bone turnover markers in top-level female skiers.The potential value of monitoring bone turnover markers among women on alendronate.Relationship between bone mineral density changes and risk of fractures among patients receiving calcium with or without vitamin D supplementation: a meta-regression.A new insight to bone turnover: role of ω-3 polyunsaturated fatty acids.
P2860
Q33632710-7707441C-26EC-41B9-87AF-6DE989FBBB1CQ33831291-199490B8-8234-486C-8129-A5D7E2AE1E74Q34031943-99B060C3-2E34-4CBB-B014-DFCFB2465AF7Q35670217-82E1B681-307E-4AB8-B65D-5C0DD8FDAE5AQ36153174-65F0BDAC-1106-4C63-8223-F848D75A78A0Q37731292-1500C2F2-623A-4B30-A69F-AE65C7021EAFQ38066699-1B78CF94-F269-4AC4-ACD4-CCBA86BC9A08Q38124052-A5A85FDE-0E4D-42E1-BD28-F02EF4826240Q40659866-F52607C9-9A88-4A71-AA70-D8095A56DC85Q40688871-BDF44F62-59E3-42AA-9325-8E74792ADC04Q42406589-490ADF4A-192E-4055-9A46-26DC33674A41Q44912560-E4AFE675-F682-4269-A692-DC7D9D9458D9Q51152611-375E5CDB-1B33-4DE6-AEF5-059732E1EC77Q51170565-6789A93C-1911-46C5-8AC2-47AA2548089EQ53076433-6F07B862-2620-429F-A414-72EDDD32246EQ54494440-001CFCD0-ADAE-427A-9EFD-71C3D247FE96
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Monitoring osteoporosis treatment.
@en
Monitoring osteoporosis treatment.
@nl
type
label
Monitoring osteoporosis treatment.
@en
Monitoring osteoporosis treatment.
@nl
prefLabel
Monitoring osteoporosis treatment.
@en
Monitoring osteoporosis treatment.
@nl
P1476
Monitoring osteoporosis treatment.
@en
P2093
Juliet Compston
P304
P356
10.1016/J.BERH.2009.09.007
P577
2009-12-01T00:00:00Z